US Stock MarketDetailed Quotes

RDY Dr. Reddy's Laboratories

Watchlist
  • 14.150
  • -0.940-6.23%
Close Jan 23 16:00 ET
  • 14.584
  • +0.434+3.07%
Post 18:29 ET
11.79BMarket Cap19.12P/E (TTM)

Dr. Reddy's Laboratories Key Stats

Dr. Reddy's Laboratories Q3 2025 Estimates Date

Currency:USDJan 23, 2025

Estimate YoY
Revenue
949.54M
+9.53%
Buy

Jan 17, 2025

Dr. Reddy's Laboratories Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: INR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 88.456B--
--2025/Q4-- / 84.179B--
Jan 23, 20252025/Q383.586B / 81.178B--
Nov 5, 20242025/Q280.162B / 76.929B--
Jul 27, 20242025/Q176.727B / 72.711B--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 88.456B--
--2025/Q4-- / 84.179B--
Jan 23, 20252025/Q383.586B / 81.178B--
Nov 5, 20242025/Q280.162B / 76.929B--
Jul 27, 20242025/Q176.727B / 72.711B--

Unlock Free Earnings Estimates

Dr. Reddy's Laboratories Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 17, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data